RVMDRevolution Medicines, Inc.
$189.76+336% 1Y
$189.76
$42.5152 weeks$216.19
The financials
Revolution Medicines, Inc. by the numbers
For the full year FY2025, revenue was $0 and net income −$1.13B. The next results filing is expected around Nov 4, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$505M | −$265M | n/a |
| Net income | −$644M | −$248M | n/a |
| Diluted EPS | −$3.06 | −$1.31 | n/a |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Mar 2023Total $7.0M (+109%)
Collaboration grew -7.4% year on year
Segment Latestquarter on quarteryear on year
- Collaboration$7.0M$7.0Mquarter on quarter +109%year on year -7.4%+109%-7.4%